Skip to main content
Skip to main content
Overview
About Us
Our Science
Pipeline
Clinical Trials
News Center
Investors
Overview
Press Releases
Events & Presentations
Stock Information
Stock Information
Analyst Coverage
Financials & Filings
Overview
Quarterly Results
SEC Filings
Irish Statutory Financial Statements
Proxy Statements
Corporate Governance
Corporate Governance
Committee Composition
Executive Management
Board of Directors
Investor Resources
Investor Email Alerts
Careers
Contact us
Follow us
Overview
Press Releases
Events & Presentations
Stock Information
Financials & Filings
Corporate Governance
Investor Resources
Event Details
AHA25: Late-Breaking Presentation of Primary Results from the Phase 2 Coramitug Clinical Trial in ATTR-CM
November 10, 2025 2:00 PM CT
AHA25: Coramitug Phase 2 Late-Breaking Presentation
(opens in new window)